Inventor · disambiguated record
Heather Davis
Also filed as: DAVIS HEATHER · DAVIS HEATHER M · DAVIS HEATHER MICHELE
17 granted patents·9 pending applications·255 citations·filing 2003–2021
95Inventor score
Top patents by PatentIndex Score
26 records- 0198US10421732B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Sep 24, 2019·16 cites·13 claims
- 0298US10214500B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Feb 26, 2019·20 cites·35 claims
- 0398US9630922B23-spiro-7-hydroxamic acid tetralins as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Apr 25, 2017·49 cites·33 claims
- 0497US10988450B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Apr 27, 2021·6 cites·14 claims
- 0597US10464910B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Nov 5, 2019·12 cites·15 claims
- 0697US10464909B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Nov 5, 2019·12 cites·17 claims
- 0797US10457652B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Oct 29, 2019·12 cites·18 claims
- 0897US10442776B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Oct 15, 2019·15 cites·18 claims
- 0997US9637453B23-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted May 2, 2017·51 cites·31 claims
- 1097US9428495B2Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2014·Granted Aug 30, 2016·35 cites·32 claims
- 1192US11891365B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO HEALTH INC·Filed 2021·Granted Feb 6, 2024·1 cites·23 claims
- 1285US7666875B2Hydantoin compoundsEISAI R&D MAN CO LTD·Filed 2006·Granted Feb 23, 2010·11 cites·30 claims
- 1382US7202363B2Thienopyridine and furopyridine kinase inhibitorsABBOTT LAB·Filed 2004·Granted Apr 10, 2007·12 cites·9 claims
- 1470US7737160B2Thienopyridine and furopyridine kinase inhibitorsABBOTT LAB·Filed 2007·Granted Jun 15, 2010·2 cites·16 claims
- 1569US8273736B2Thienopyridine and furopyridine kinase inhibitorsBETSCHMANN PATRICK·Filed 2009·Granted Sep 25, 2012·1 cites·14 claims
- 1669US2021179556A1Primary carboxamides as btk inhibitorsABBVIE INC·Filed 2021·Application pending·0 cites
- 1766US2019284135A1Primary carboxamides as btk inhibitorsABBVIE INC·Filed 2019·Application pending·0 cites
- 1865US9567339B2Primary carboxamides as BTK inhibitorsABBVIE INC·Filed 2014·Granted Feb 14, 2017·0 cites·20 claims
- 1964US2018354939A1Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2018·Application pending·0 cites
- 2062USRE47193ESelectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2017·Granted Jan 8, 2019·0 cites·32 claims
- 2160US2016326161A1Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2016·Application pending·0 cites
- 2258US2017174624A1Primary carboxamides as btk inhibitorsABBVIE INC·Filed 2017·Application pending·0 cites
- 2344US2014315883A16H-IMIDAZO[1,5-a]PYRROLO[2,3-e]PYRAZINE COMPOUNDSBREINLINGER ERIC·Filed 2014·Application pending·0 cites
- 2444US2005026944A1Thienopyridine and furopyridine kinase inhibitorsFiled 2004·Application pending·0 cites
- 2541US2005020619A1Thienopyridine kinase inhibitorsFiled 2003·Application pending·0 cites
- 2639US2010113446A1Hydantoin compoundsGALLAGHER JR BRIAN M·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Heather Davis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →